Skip to main content
XCUR
NASDAQ Life Sciences

Major Shareholder Exicure HiTron Sells $3.3M in EXICURE Stock, Reducing Stake to 40.7%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$5.76
Mkt Cap
$37.478M
52W Low
$3.101
52W High
$15.91
52W Position info
86% above low
Off High info
64% below high
Rel. Volume
Market data snapshot near publication time

XCUR sits 86% above its 52-week low of $3.101.

Summary

Exicure HiTron Inc., a significant shareholder, sold 741,272 shares of EXICURE, INC. common stock for $3.3 million, reducing its beneficial ownership to 40.7%.


Key Events · Ownership and Investor Activity · XCUR

  • Major Shareholder Reduces Stake

    Exicure HiTron Inc. sold 741,272 shares of EXICURE, INC. common stock on January 7, 2026.

  • Significant Transaction Value

    The shares were sold at a price of $4.50 per share, totaling $3,335,724 in proceeds.

  • Post-Sale Ownership

    Following the transaction, Exicure HiTron Inc. beneficially owns 2,592,061 shares, representing approximately 40.7% of the outstanding common stock.

  • Stated Purpose

    The shares were transferred for liquidity purposes.


Analysis · XCUR · Life Sciences

This Schedule 13D/A reports a substantial sale of shares by Exicure HiTron Inc., a major institutional investor in EXICURE, INC. The sale of over $3.3 million worth of stock, representing a significant portion of the company's market capitalization and over 20% of Exicure HiTron's previous holdings, is a material reduction in their stake. While cited for "liquidity purposes," such a large disposition by a key shareholder can be interpreted negatively by the market, potentially signaling a shift in their investment thesis or a need for capital elsewhere. Investors should monitor future filings for further changes in ownership by this entity.

At the time of this filing, XCUR was trading at $5.76 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $37.5M. The 52-week trading range was $3.10 to $15.91. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

XCUR - Latest Insights

XCUR
Jul 17, 2026, 4:39 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $1.63
Real-time Price: $1.74 info
Change: +$0.110 (+7%) info
Market Cap: $11.091M info
XCUR
Jul 17, 2026, 1:05 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $1.67
Real-time Price: $1.74 info
Change: +$0.075 (+5%) info
Market Cap: $11.091M info
XCUR
Jun 30, 2026, 3:03 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $2.00
Real-time Price: $1.74 info
Change: -$0.2616 (-13%) info
Market Cap: $11.091M info
XCUR
Jun 30, 2026, 2:55 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.03
Real-time Price: $1.74 info
Change: -$0.290 (-14%) info
Market Cap: $11.091M info
XCUR
May 29, 2026, 2:09 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.16
Real-time Price: $1.74 info
Change: -$1.42 (-45%) info
Market Cap: $11.091M info